Reinforced staplers for distal pancreatectomy
Manabu Kawai(Wakayama Medical University), Hiroki Yamaue(Wakayama Medical University), Yoshiaki Murakami(Hiroshima University), Seiko Hirono(Wakayama Medical University), Yutaka Takeda(Osaka National Hospital), Masanori Kon(Kansai Medical University), Hirochika Toyama(Kobe University), Hiroaki Yanagimoto(National Cancer Center Hospital East), Hisashi Ikoma(Hyogo Medical University), Masayuki Sho(Nara Medical University), Tsutomu Fujii(University of Toyama), Takumi Fukumoto(Kobe University), Hidetoshi Eguchi(Osaka Gakuin University), Sohei Satoi(Kansai Medical University), Naru Kondo(Hiroshima University), Ken‐ichi Okada(Wakayama Medical University), Jiro Fujimoto(Harvard University), Takahiro Akahori(Nara Medical University), Ippei Matsumoto(Kindai University)
Cited by 39
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
|Japanese Journal of Clinical Oncology|2018|534